Dr. Sulima Fakeeh Hospital
Jeddah, Mecca Region, 23717, Saudi Arabia
NCT Number: NCT07816354
This study aims to evaluate whether an MBI improves sleep quality, emotional symptoms (depression, anxiety, stress), emotion regulation, and trait mindfulness among adults with ESRD on HD. A randomized two-arm pre-post design was conducted with N = 38 patients at Dr. Soliman Fakeeh Hospital (DSFH), Saudi Arabia (n = 19 intervention; n = 19 control). The intervention comprised 30-minute guided sessions, 3 times a week for 5 weeks during HD sessions. The control group received the study intervention after the study. Outcomes were assessed at baseline and post-intervention using the Pittsburgh Sleep Quality Index (PSQI), Depression Anxiety Stress Scale-21 (DASS-21), Emotion Regulation Questionnaire (ERQ), and Mindful Attention Awareness Scale (MAAS).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Jeddah, Mecca Region, 23717, Saudi Arabia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention was a structured audio-based MBI program over a five-week period during regular hemodialysis procedure. The program, delivered using validated audio recordings, drew on the principles of mindfulness-based stress reduction (MBSR) and was tailored to the needs of hemodialysis patients . The intervention group participated in daily 30-minute sessions of guided MBI three times a week for five weeks. These sessions took place during the dialysis sessions to improve the feasibility and avoid placing further burdens on participants. The mindfulness intervention involved a number of key elements, such as focusing on the breathing, body scanning, awareness of the present moment and nonreactive monitoring of thoughts and feelings. Participants were advised to become mindful of their thoughts, feelings, and sensations, without trying to change them. The program also taught acceptance-based approaches and cognitive diffusion from negative thought
Time frame: From enrollment to the end of intervention at 5 weeks
It is used to gain a broad understanding of sleep architecture over the previous 30 days. This 19-item self-report questionnaire assesses seven components of sleep: sleep quality; sleep latency (time to fall asleep); sleep duration; sleep efficiency (time asleep, relative to total time in bed); sleep disturbances; use of sleeping medication; and daytime dysfunction (Buysse et al., 1989). The score for each component ranges from 0 to 3. Added together, the scores of the seven components produce a Global Sleep Quality Score, ranging from 0 to 21.
Time frame: From enrollment to the end of intervention at 5 weeks
The DASS-21 was used to assess the psychological distress of having end-stage renal disease. This scale includes three 7-item subscales that distinguish between the key elements of depression (e.g., dysphoria, hopelessness), anxiety (e.g., autonomic arousal, skeletal muscle effects) and stress (e.g., irritability, impatience). Respondents are asked to respond on a 4-point Likert scale according to how they have felt in the last week. As a shortened form of the original 42-item DASS, the scores of each of the three DASS-21 subscales are doubled to reflect ratings for the standard severity levels (from "Normal" to "Extremely Severe")
Time frame: From enrollment to the end of intervention at 5 weeks
The ERQ assesses how participants regulate their emotions in response to the stressful situation of living with chronic illness. This 10-item questionnaire assesses two distinct strategies of emotion regulation, including cognitive reappraisal (6 items) and expressive suppression ( 4 items). Cognitive Reappraisal is an antecedent-focused strategy that involves changing the way one thinks about a stressful situation in order to modify its emotional effect (e.g., "When I am feeling down, I change the way I think about the situation to improve the way I feel"). Expressive Suppression is a response-focused strategy by which individuals control their emotions by suppressing their expression (e.g., "I keep my emotions to myself"). Responses are scored from 1 to 7 (1 = I strongly disagree, 7 = I strongly agree). Generally, higher reappraisal scores are associated with better mental health, and higher suppression scores with greater mental distress.
Time frame: From enrollment to the end of intervention at 5 weeks
The MAAS is used to measure "trait mindfulness" - the tendency to be aware of present-moment experiences in a nonjudgmental, nonreactive way. It This 15-item questionnaire measures the trait-like presence or absence of attention to current moment experiences rather than religious or meditative practices. Respondents rate items (e.g., "I find myself doing things without paying attention") on a 6-point scale (1 = almost always to 6 = almost never). A higher mean score indicates higher trait mindfulness.
Jordan University of Science and Technology
Other
The Effect of Mindfulness_Based Intervention on Sleep Quality, Emotional Symptoms, and Emotion Regulation Among Saudi Patients Receiving Hemodialysis
Acronym: MSHP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05552482
Arteriovenous Fistula, Arteriovenous Malformations
Metz, France
View Trial DetailsNCT07518017
Chronic Disease, Chronic Kidney Disease
Siirt, Turkey (Türkiye)
View Trial DetailsNCT06759376
Chronic Disease, Chronic Kidney Disease
Eskişehir, Turkiye, Turkey (Türkiye)
View Trial DetailsNCT07760285
Arthralgia, Bursitis
Cairo, Menofyia, Egypt
View Trial Details